Dolores Schendel

Dolores Schendel

Company: Medigene

Job title: CEO & CSO


Empowering TCR-Ts to Infiltrate, Proliferate and Control Solid Tumors in a Hostile TME 12:40 pm

Selection of an antigen-specific and sensitive TCR for a good tumor target is the starting point for successful control of solid tumors Modification of TCR-Ts themselves to express a PD1-41BB switch receptor fosters improved T cell functions in a hostile TME We demonstrate the power of this intrinsic combination of signals to control tumor growth…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.